Parenteral devices

Complex devices, simple patient care

The growing prevalence of chronic diseases, along with the evolution of self-administration at home, is driving new ways of administrating parenteral drugs. As injecting a drug means increased risks of use errors and needlestick injuries, self-administration at home translates into a need for safer, easy-to-use and ergonomic devices.
We are committed to ensure adherence and user well-being for patients and healthcare professionals providing a comprehensive parenteral product range that matches their need.



We developed a portfolio of devices to deliver implants with integrated needlestick protection. As implants can vary a lot, we support your projects and explore design attributes which will increase the user experience such as improved holding and priming, improved motion for implant insertion, etc.

Discover More


Nemera’s wearables: a unique on-body injector offering, to improve patients’ injection experience.

Discover More

Our services

Integrated services from device selection to GMP manufacturing

We have developed end-to-end services and expertise in device development, device consulting, and contract manufacturing to complement our diverse portfolio of products to help you through every step of the journey.

Discover more
Manufacturing planning-device selection-services

Early-stage innovation

Our front-end innovation, design research, human factors expertise enhances our capabilities in gaining a full understanding of the patient journey to ensure a successful drug/device combination product.

Discover more
Design Research- Insight Innovation Center capabilities-Services

Testing services for customer formulations

Thanks to our cutting-edge laboratory service, our comprehensive test range assures compliant and reliable parenteral drug/device combination products.

Discover more
Advanced R&D- Test Safe'n'Sound-Device selection-services


Subcutaneous injection is a highly effective route to administer various drug types including small molecules and biologic drugs.
Our parenteral device range is used to treat patients with hormonal disorders such as diabetes and infertility. Besides, patients with other chronic conditions such as immune disorders could also benefit safety coupled with an enhanced injection experience from using our devices.

The safety mechanism in an active safety system needs to be activated manually by users.
On the other hand, a passive safety system does not require users to do any additional steps to activate the safety mechanism to prevent accidental needlesticks, hence is a more user-friendly device.

Pen injectors typically use a cartridge system coupled with a multidose formulation. Disposable pen injectors come ready to use, with a set amount of drug available in a cartridge (prefilled pen). Prefilled pens are disposed of when the drug in the cartridge is depleted.
A reusable pen injector contains a replaceable cartridge with medicine inside. Once the cartridge is empty it can be discarded and replaced with a new one. Reusable pens are meant to be used for an extended period of time, allowing the patient to use the same device even for several years.

Although diabetes account for vast majority of total pen volumes worldwide other therapeutic areas are growing. Outside insulin and GLP-1 administration sector, systemic hormones and fertility cover the largest segment. In general pen injectors usually use a cartridge system for a multidose formulation, making them potentially suitable for any drug available in a cartridge.
With an in-depth analysis of the intended use, preferences of the target group as well as needs, expectations and limitations of patients, our product platforms offer a range of injection devices, for an administration of a wide range of pharmaceutical products, including insulin pen injectors (for human, glargine, lispro, aspart), somatropin pen injectors, follistim pen injectors, teriparatide pen injectors, exenatide pen injectors, pramlintide pen injectors and liraglutide pen injectors.

With a growing tendency of self-administration at home, patients wish for independence and confidence in taking their medications with safety. In line with this, drug regimen is switching from intravenous to subcutaneous route to facilitate self-administration without healthcare professional’s intervention. Besides, new molecules are being developed and injecting a high viscous biologic formulation could be challenging.
Our robust, easy-to-use on-body injector device answers these growing needs and helps reaching seamless delivery with safety and comfort.